| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | HK$12.22 |
| 52 Week High | HK$13.04 |
| 52 Week Low | HK$6.02 |
| Beta | 0.19 |
| 1 Month Change | 16.38% |
| 3 Month Change | 38.55% |
| 1 Year Change | 65.81% |
| 3 Year Change | 39.02% |
| 5 Year Change | -39.20% |
| Change since IPO | 68.09% |
Noticias y actualizaciones recientes
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01
Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03Recent updates
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30Rentabilidad de los accionistas
| 1558 | HK Pharmaceuticals | Mercado HK | |
|---|---|---|---|
| 7D | -3.6% | -4.5% | -2.0% |
| 1Y | 65.8% | -21.8% | -14.3% |
Rentabilidad vs. Industria: 1558 superó al sector Hong Kong Pharmaceuticals , que obtuvo un rendimiento del -20% el año pasado.
Rentabilidad vs. Mercado: 1558 superó al mercado Hong Kong, que obtuvo un rendimiento del -16.4% el año pasado.
Volatilidad de los precios
| 1558 volatility | |
|---|---|
| 1558 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.8% |
Precio estable de las acciones: El precio de las acciones de 1558 ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 1558 (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2001 | 4,618 | Juncai Jiang | cj.hec.cn |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. desarrolla, fabrica y vende productos farmacéuticos en las áreas terapéuticas de antivirus, enfermedades endocrinas y metabólicas, enfermedades cardiovasculares y enfermedades antiinfecciosas en la República Popular China. Fabrica y vende principios activos farmacéuticos; investiga y desarrolla productos farmacéuticos y dispositivos y fármacos médicos, así como biotecnología; y presta servicios de consultoría médica.
Resumen de fundamentos de YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
| Estadísticas fundamentales de 1558 | |
|---|---|
| Capitalización bursátil | HK$10.75b |
| Beneficios(TTM) | HK$2.16b |
| Ingresos (TTM) | HK$6.81b |
5.0x
Ratio precio-beneficio (PE)1.6x
Ratio precio-ventas (PS)¿Está 1558 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 1558 | |
|---|---|
| Ingresos | CN¥6.29b |
| Coste de los ingresos | CN¥1.31b |
| Beneficio bruto | CN¥4.99b |
| Otros gastos | CN¥2.99b |
| Beneficios | CN¥1.99b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 2.26 |
| Margen bruto | 79.21% |
| Margen de beneficio neto | 31.66% |
| Ratio deuda/patrimonio | 32.9% |
¿Cómo se ha desempeñado 1558 a largo plazo?
Ver rendimiento histórico y comparativa